戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 rm that ketamine exerts a specific effect on suicidal ideation.
2  the effects of a single dose of ketamine on suicidal ideation.
3  been studied in patients with low levels of suicidal ideation.
4 students are at high risk for depression and suicidal ideation.
5 phine as a time-limited treatment for severe suicidal ideation.
6 include data on suicide, suicide attempt, or suicidal ideation.
7 d 191 (60%) of 321 patients had a history of suicidal ideation.
8 ) BPF, suggesting a role for both regions in suicidal ideation.
9  at risk for attempts among respondents with suicidal ideation.
10   Analyses yielded similar results examining suicidal ideation.
11  associations were found in individuals with suicidal ideation.
12 ethality and intent of suicide attempts; and suicidal ideation.
13 among individuals with a lifetime history of suicidal ideation.
14 h psoriasis had significant association with suicidal ideation.
15 ies included women with severe depression or suicidal ideation.
16  Lifetime presence of self-reported NSSI and suicidal ideation.
17 ences underlie the vulnerability to NSSI and suicidal ideation.
18  Health Questionnaire-9, which also assessed suicidal ideation.
19  fatigue, but not sadness, worthlessness, or suicidal ideation.
20 her incidence rates of anxiety disorders and suicidal ideation.
21 of substance abuse, risk-taking behavior, or suicidal ideation.
22 r income-and subsequent suicide attempts and suicidal ideation.
23 on with a suicide attempt history or current suicidal ideation.
24 rsonal implications for physicians including suicidal ideation.
25 ons from Iraq for mental health reasons, and suicidal ideation.
26 ders that could lead to both weight loss and suicidal ideation.
27 elf-harm adverse events in those with higher suicidal ideation.
28  influenced by the presence of depression or suicidal ideation.
29 ecovery from burnout is associated with less suicidal ideation.
30 d higher rates of symptoms of depression and suicidal ideation.
31 al factors and suicide, suicide attempt, and suicidal ideation.
32 ith major depressive disorder, insomnia, and suicidal ideation.
33 ssociated with suicide, suicide attempt, and suicidal ideation.
34 verity of suicidal risk in MDD patients with suicidal ideation.
35  about one out of eight stroke survivors has suicidal ideation.
36 information integration in MDD patients with suicidal ideation.
37 antly negatively correlated with severity of suicidal ideation.
38 hat hypnotic medications are associated with suicidal ideation.
39 mate, suggesting a possible association with suicidal ideation.
40  for up to 1 week in depressed patients with suicidal ideation.
41 (SMD=-0.22; p=0.03) were all associated with suicidal ideation.
42 reased sleep, feelings of worthlessness, and suicidal ideations.
43 ts than did those in unscreened brigades for suicidal ideation (0.4%, 95% CI=0.3-0.5, compared with 0
44 io [OR] 0.45, 95% CI 0.24-0.85; p=0.014) and suicidal ideation (0.5, 0.27-0.92; p=0.025).
45  0.45, 95% CI 0.24-0.85; p=0.014) and severe suicidal ideation (0.50, 0.27-0.92; p=0.025), compared w
46   243 (66%) of 367 respondents self-reported suicidal ideation, 127 (35%) of 365 respondents self-rep
47 rticipants), but not with treatment-emergent suicidal ideation (13 [21%] of 61 vs 19 [29%] of 65 part
48  patient), suicide attempt (4 patients), and suicidal ideation (2 patients).
49  MDD (odds ratio 1.98, 95% CI 1.11-3.53) and suicidal ideation (2.47, 1.19-5.10) compared with their
50 oth NSSI (37% for men and 59% for women) and suicidal ideation (41% for men and 55% for women), while
51 an first- and second-year students to report suicidal ideation (7.9% vs 1.4%; 95% CI for difference,
52 r Suicide, CFI-S), and how well they predict suicidal ideation across psychiatric diagnoses (AUC of 8
53   Indeed, the UP-Suicide was able to predict suicidal ideation across psychiatric diagnoses with an A
54  GRIK2 (which likely play a role in emergent suicidal ideation after antidepressant treatment), GRIK4
55 derstanding of the epidemiological impact of suicidal ideation after stroke is required to identify s
56 and early interventions to prevent and treat suicidal ideation after stroke, especially among subject
57 d to experience greater acute improvement in suicidal ideation, after adjusting for global depression
58 ram is associated with reduced likelihood of suicidal ideation among medical interns.
59 is a concerning prevalence of depression and suicidal ideation among medical students, a group that m
60                     The pooled proportion of suicidal ideation among stroke survivors was 11.8% (7.4%
61 ysis was to estimate rates and correlates of suicidal ideation among stroke survivors.
62      Little is known about the prevalence of suicidal ideation among U.S. medical students or how it
63 onnectivity in 46 patients with MDD (23 with suicidal ideation and 23 without) and 36 age- and gender
64  structures in 48 patients with MDD (24 with suicidal ideation and 24 without) and 25 age- and sex-ma
65 activity subtypes of MDD patients had severe suicidal ideation and anhedonia symptoms.
66 nectivity may be associated with severity of suicidal ideation and attempt lethality.
67                                     Concrete suicidal ideation and attempts during adolescence are pa
68 reater comorbidities, and increased risk for suicidal ideation and attempts in individuals with mood
69 on is a risk factor for child and adolescent suicidal ideation and attempts.
70 SRS's validity relative to other measures of suicidal ideation and behavior and the internal consiste
71                                              Suicidal ideation and behavior currently have no quick-a
72 hat the C-SSRS is suitable for assessment of suicidal ideation and behavior in clinical and research
73 ivergent validity with other multi-informant suicidal ideation and behavior scales and had high sensi
74 equires a standard method for assessing both suicidal ideation and behavior to identify those at risk
75 RS) was designed to quantify the severity of suicidal ideation and behavior.
76 onpharmacologic approaches for patients with suicidal ideation and behavior.
77 en right rostral prefrontal connectivity and suicidal ideation and between left ventral prefrontal co
78  the precision of the estimated frequency of suicidal ideation and burnout.
79 sychotic or demented people, those with both suicidal ideation and clear intent, and those with subst
80  impact of a care management intervention on suicidal ideation and depression in older primary care p
81 subjects, and had an increased prevalence of suicidal ideation and depressive symptoms.
82 he intervention decreases the probability of suicidal ideation and hazardous drinking in adolescence
83 y genes that change in expression between no suicidal ideation and high suicidal ideation states (n=3
84 he prefrontal regions, may favor more severe suicidal ideation and higher-lethality suicide attempts.
85 erotonin1A binding potential predicts future suicidal ideation and intent and lethality of future sui
86 ion of suicidal behavior, its lethality, and suicidal ideation and intent.
87 e (1%) participant in the the placebo group, suicidal ideation and intentional overdose in one (1%) p
88 reased risk of suicide, suicide attempt, and suicidal ideation and is a significant public health pro
89  few studies have focused on the severity of suicidal ideation and its association with subcortical a
90 czema in late adolescence is associated with suicidal ideation and mental health problems but rarely
91 rotonin1A binding potential predicted higher suicidal ideation and more lethal suicidal behavior duri
92 ion, but they may also heighten the risk for suicidal ideation and parasuicidal behavior.
93               Self-harm behaviors, including suicidal ideation and past suicide attempts, are frequen
94 tal health, using measures of overweight and suicidal ideation and planning which some have shown to
95 ization is related to an increased chance of suicidal ideation and suicide attempts among children an
96                                 Twelve-month suicidal ideation and suicide attempts.
97                        This study focused on suicidal ideation and suicide attempts.
98 timization was hypothesized to be related to suicidal ideation and suicide attempts.
99 red the lifetime experience of self-reported suicidal ideation and suicide plans or attempts in this
100  autistic traits, empathy, and likelihood of suicidal ideation and suicide plans or attempts.
101 n firing and release, which affects mood and suicidal ideation and thereby decision making.
102 e-duty military service members with current suicidal ideation and/or a recent suicide attempt.
103  psychiatric outcomes (depression, PTSD, and suicidal ideation and/or self-harm) were scored by inter
104 review to understand the association between suicidal ideations and behaviours and economic poverty i
105 uded studies testing the association between suicidal ideations and behaviours and economic poverty i
106 orting on the relationship between non-fatal suicidal ideations and behaviours and poverty, 36 associ
107  wealth, and unemployment is associated with suicidal ideations and behaviours.
108  compare prevalences of depression, anxiety, suicidal ideation, and anxiety attacks, in adults with a
109 polar or severe personality disorder, active suicidal ideation, and current antipsychotic or antidepr
110 depression, by targeting of family conflict, suicidal ideation, and drug use may help to reduce their
111 oral therapy (CBT) reduces suicide attempts, suicidal ideation, and hopelessness compared with treatm
112 utilization of depression treatment, reduces suicidal ideation, and improves the outcomes of major de
113               Reporting of depression, PTSD, suicidal ideation, and interest in receiving care were 2
114 ondary outcomes of depression, hopelessness, suicidal ideation, and problem solving.
115 5D visual analogue scale, sociodemographics, suicidal ideation, and stress (negative life events and
116 recording lifetime experience of depression, suicidal ideation, and suicide plans or attempts, along
117  positive internal states that can stimulate suicidal ideation, and that impairments in a DPFC and in
118 ssion, atopic dermatitis was associated with suicidal ideation, and that parental emotional support m
119 atures such as depressive symptomatology and suicidal ideation, and the outcome of treatment for depr
120 ere present in MDD patients with and without suicidal ideation; and supplemented comparison with and
121 nce of depression or depressive symptoms and suicidal ideation; and whether students who screened pos
122 epression (AOR, 2.27; 95% CI, 1.22-4.23) and suicidal ideation (AOR, 3.43; 95% CI, 1.80-6.54).
123  anxiety (AOR, 2.13; 95% CI, 1.12-4.05), and suicidal ideation (AOR, 3.68; 95% CI, 1.77-7.67).
124                     Depression, anxiety, and suicidal ideation are more common among AD individuals,
125 ajor depressive disorder (MDD) patients with suicidal ideation are poorly understood.
126 lence of depression, depressive symptoms, or suicidal ideation as assessed by validated questionnaire
127    The primary outcome measure was change in suicidal ideation, as assessed by the Beck Suicide Ideat
128 serotonin1A binding potential predicted more suicidal ideation at 3 (b = 0.02; t = 3.45; P = .001) an
129  analysis included only participants who had suicidal ideation at baseline (N=167).
130 ent resistance, 58 (12%) of 465 patients had suicidal ideation at screening, and 191 (60%) of 321 pat
131 traumatic stress disorder; anxiety disorder; suicidal ideation/attempt; nicotine dependence; alcohol
132 the overall effects of sleep disturbances on suicidal ideation, attempts, and death.
133        Predefined outcomes were (1) rates of suicidal ideation based on random-effects pooled proport
134        No changes in mood or self-reports of suicidal ideation/behavior were observed.
135     Although pain and suicidality (including suicidal ideation, behaviour, and death by suicide) both
136 Inventory-II (BDI-II) and the Beck Scale for Suicidal Ideation (BSSI).
137  decreased biomarkers from the discovery for suicidal ideation (CADM1, CLIP4, DTNA, KIF2C), prioritiz
138 lity to suicidal attempt can be derived from suicidal ideation combined with depression and impulsivi
139 nterns (12 of 100) assigned to wCBT endorsed suicidal ideation compared with 21.2% of interns (21 of
140 ng those with current eczema, 15.5% reported suicidal ideation compared with 9.1% among those without
141 BT and DBT showed modest benefit in reducing suicidal ideation compared with TAU or wait-list control
142   Cyberbullying was more strongly related to suicidal ideation compared with traditional bullying.
143 t dialectical behavior therapy (DBT) reduces suicidal ideation compared with wait-list control or cri
144 aphic information, negative life events, and suicidal ideation; depression and anxiety were assessed
145                   Symptoms of depression and suicidal ideation did not differ significantly between f
146                                     Rates of suicidal ideation diminished to a substantially greater
147                                              Suicidal ideation due to abortion has been used to justi
148 assigned to wCBT were less likely to endorse suicidal ideation during internship year (relative risk,
149 udents experience burnout and 10% experience suicidal ideation during medical school.
150 er attempted suicide or who had shown severe suicidal ideation during the 2 weeks before baseline.
151 ly use and frequent use of cannabis and MDD, suicidal ideation (ever and persistent), and suicide pla
152 12, lower depression, hopelessness, anxiety, suicidal ideation, family conflict, and absence of comor
153 vent was 3 weeks, predicted by high baseline suicidal ideation, family conflict, and drug and alcohol
154 etwork was observed in patients with MDD and suicidal ideation (FDR-adjusted p < 0.05).
155 o are most likely to experience remission of suicidal ideation following a course of MST.
156 psychotic experiences among individuals with suicidal ideation has potential clinical and public heal
157 etween no suicidal ideation (no SI) and high suicidal ideation (high SI) states (n=12 participants ou
158 ations were observed for suicide attempt and suicidal ideation; however, these results were based on
159 nt Health Questionnaire-9 was used to assess suicidal ideation (ie, "thoughts that you would be bette
160                               Depression and suicidal ideation improved equally with both formats.
161 t to anecdotal reports of increased rates of suicidal ideation in adults with Asperger's syndrome, an
162 iption of hypnotic medication for mitigating suicidal ideation in all depressed outpatients with inso
163 may lead to a small increase in the risk for suicidal ideation in children and adolescents, the risk
164  greater reduction in clinically significant suicidal ideation in depressed patients within 24 hours
165           Pharmacotherapy to rapidly relieve suicidal ideation in depression may reduce suicide risk.
166 ETATION: The increased likelihood of MDD and suicidal ideation in frequent cannabis users cannot be s
167  This study investigated specific changes of suicidal ideation in functional connectivity of MDD pati
168                                  Severity of suicidal ideation in MDD is related to brainstem and pre
169 eft orbitofrontal-both thalamic regions with suicidal ideation in MDD were inversely proportional to
170 lence of depression, depressive symptoms, or suicidal ideation in medical students published before S
171 ence of depression, depressive symptoms, and suicidal ideation in medical students.
172 travenous ketamine on clinically significant suicidal ideation in patients with major depressive diso
173 he outcomes of suicide, suicide attempt, and suicidal ideation in relatives, friends, and acquaintanc
174 ng the number of suicide attempts and severe suicidal ideation in school-based adolescents.
175  buprenorphine was associated with decreased suicidal ideation in severely suicidal patients without
176 elated side effects including depression and suicidal ideation in some users.
177 eation in the sample with published rates of suicidal ideation in the general population and other cl
178                      There were six cases of suicidal ideation in the group receiving pregabalin, thr
179 ot have suicidal ideation, the prevalence of suicidal ideation in the past 12 months would be 5.8%.
180                                Prevalence of suicidal ideation in the past year and its relationship
181                      We compared the rate of suicidal ideation in the sample with published rates of
182 d 15 pupils (0.75%) reported incident severe suicidal ideation in the YAM group versus 31 (1.37%) in
183 ion, we found that ketamine rapidly improved suicidal ideation in these patients.
184    In a subgroup analyses, the prevalence of suicidal ideation in those with both eczema and itch was
185 ysicians are at particularly high risk, with suicidal ideation increasing more than 4-fold during the
186 ve previously shown to increase the risk for suicidal ideation, interns assigned to wCBT were less li
187 ead to very high risk circumstances in which suicidal ideation is converted to lethal actions via dec
188 the substantial correlation between NSSI and suicidal ideation is largely driven by overlapping genet
189                                              Suicidal ideation is often associated with TRD and contr
190 eated measures of weight, mental health, and suicidal ideation, it remains difficult to exclude the p
191  social signs, excessive emotional pain, and suicidal ideation, leading to suicidal behaviour.
192  model adjusted for baseline depression, for suicidal ideation measured with the Beck Scale for Suici
193 e-based study to explore the relationship of suicidal ideation, mental health problems, and social fu
194 f psychiatric participants for prediction of suicidal ideation (n=108), and in a future follow-up coh
195 equently falls (n=5), suicide attempt (n=4), suicidal ideation (n=3), head injury (n=3), and aspirati
196 ls with depression, and its association with suicidal ideation, needs further clarification.
197 y genes that change in expression between no suicidal ideation (no SI) and high suicidal ideation (hi
198 out misuse was associated with lower odds of suicidal ideation (odds ratio (OR) = 0.57, 95% confidenc
199 in self-harm were much more likely to report suicidal ideation (odds ratio = 8.39; 95% CI, 6.84-10.29
200 iences were more likely to report concurrent suicidal ideation (odds ratio [OR], 5.24; 95% CI, 2.85-9
201 , 1.53; 95% confidence interval, 1.15-2.02), suicidal ideation (odds ratio, 1.27; 95% confidence inte
202 ictimization was found to be related to both suicidal ideation (odds ratio, 2.23 [95% CI, 2.10-2.37])
203 icide attempters study, worst-point lifetime suicidal ideation on the C-SSRS predicted suicide attemp
204    The advantage for zolpidem-CR in reducing suicidal ideation on the C-SSRS was greater in patients
205 roup and two in the DP group were related to suicidal ideation; one patient in the DP attempted suici
206                           The biomarkers for suicidal ideation only are enriched for genes involved i
207     Of all respondents, 62% had a history of suicidal ideation or attempt according to the petitioner
208 e was not a standardized questionnaire about suicidal ideation or attempt.
209                   Suicidality was defined as suicidal ideation or attempted or completed suicide.
210 egimens; suicidality was defined as reported suicidal ideation or attempted or completed suicide.
211 s disorder (PTSD) and suicide has focused on suicidal ideation or attempts; no known study of the ass
212 cally relevant differences between groups in suicidal ideation or behavior and no overall worsening o
213  follow-up and ratings of mood, anxiety, and suicidal ideation or behavior.
214      No association was found with increased suicidal ideation or behavior.
215           There was no evidence of increased suicidal ideation or behavior.
216  and those with a current or past history of suicidal ideation or behaviour (1.8% [18.78], t51=0.68;
217 d patients with a current or past history of suicidal ideation or behaviour.
218  (HR, 2.96; 95% CI, 1.24-7.08; P = .01), any suicidal ideation or gesture (HR, 2.44; 95% CI, 1.28-4.6
219 in effect or treatment x time interaction on suicidal ideation or mHDRS-17 was found.
220 a-analysis was not feasible for wellbeing or suicidal ideation or self-harm outcomes, and results are
221 parasomnias, which in rare cases may lead to suicidal ideation or suicidal behavior in persons who we
222  relationship between peer victimization and suicidal ideation or suicide attempt in children or adol
223  relationship between peer victimization and suicidal ideation or suicide attempts using meta-analysi
224 and no use was associated with lower odds of suicidal ideation (OR = 0.62, 95% CI: 0.49, 0.80), suici
225 lity (including recurrent thoughts of death, suicidal ideation, or a suicide attempt), were assessed
226  the CDRS-R, self-rated depressive symptoms, suicidal ideation, or on the rate of harm-related or any
227 lf-report anxiety and depression, wellbeing, suicidal ideation, or self-harm.
228  volume between MDD patients with or without suicidal ideations; or MDD patients with or without suic
229  evidence of an association was observed for suicidal ideation outcomes (2 studies, N = 43,354; OR =
230 ide attempt on suicide, suicide attempt, and suicidal ideation outcomes and to identify moderators of
231 -62%) and had a 2.2 times greater decline in suicidal ideation over 24 months.
232 e at baseline were independent predictors of suicidal ideation over the following year.
233 e symptoms (P < 0.001) at baseline predicted suicidal ideation over the following year.
234 me and depression were more likely to report suicidal ideation (p<0.0001) and suicide plans or attemp
235 al ideation measured with the Beck Scale for Suicidal Ideation (p=0.03), with benefit increasing with
236 Seven percent of the HCT survivors expressed suicidal ideation; patients with higher scores on depres
237                                              Suicidal ideation prevalence data were extracted from 24
238 tient Health Questionnaire-2 (modified), the suicidal ideation question from the Patient Health Quest
239                            The prevalence of suicidal ideation ranged from 1102 (24.9%) of 4432 peopl
240                         Ketamine's effect on suicidal ideation remained significant after adjusting f
241 ated that the Met allele was associated with suicidal ideation, sadness, and worthlessness, but not n
242 ion, posttraumatic stress disorder, anxiety, suicidal ideation, self-injury, and suicide attempts.
243 ignificantly predicted depression, PTSD, and suicidal ideation/self-harm and explained up to 0.6% of
244  genetic influences on depression, PTSD, and suicidal ideation/self-harm are at least partially share
245 ni biomarker list for predictive ability for suicidal ideation (SI) and for future hospitalizations f
246 tudinal association between irritability and suicidal ideation (SI) in adults with major depressive d
247                               We compared no suicidal ideation (SI) states and high SI states using a
248 D (n = 29) and MDD (n = 29) as a function of suicidal ideation (SI) to compare with that of healthy c
249 have many known risk factors for suicide and suicidal ideation (SI).
250      Ketamine rapidly (within 1 day) reduced suicidal ideation significantly on both the clinician-ad
251  40 minutes, depressive symptoms, as well as suicidal ideation, significantly improved in subjects re
252 e disorder and a score >/=4 on the Scale for Suicidal Ideation (SSI), of whom 54% (N=43) were taking
253 ession between no suicidal ideation and high suicidal ideation states (n=37 participants out of a coh
254 haviors that precede these deaths, including suicidal ideation, suicide attempts, hazardous drinking,
255         The lifetime prevalence estimates of suicidal ideation, suicide plans, and suicide attempts a
256 d associations of opioid use and misuse with suicidal ideation, suicide plans, and suicide attempts a
257 sures were associated with increased odds of suicidal ideation, suicide plans, and suicide attempts i
258                                     Lifetime suicidal ideation, suicide plans, and suicide attempts.
259 s with insomnia would provide a reduction in suicidal ideation superior to placebo.
260 more likely to report lifetime experience of suicidal ideation than were individuals from a general U
261  that assumed all nonresponders did not have suicidal ideation, the prevalence of suicidal ideation i
262                       Among respondents with suicidal ideation, those with psychotic experiences were
263                                     Reducing Suicidal Ideation Through Insomnia Treatment was an 8-we
264 crease the probability of transitioning from suicidal ideation to action.
265  progression from disturbed mental health to suicidal ideation to attempted suicide and completed sui
266     Depressed patients with greater baseline suicidal ideation treated with paroxetine compared with
267       The overall pooled crude prevalence of suicidal ideation was 11.1% (2043/21002 individuals; 95%
268 among medical students was 27.2% and that of suicidal ideation was 11.1%.
269                                              Suicidal ideation was evaluated before initiation and af
270                                    Moreover, suicidal ideation was less likely in stroke survivors wh
271 tly in patients with pHPT; the prevalence of suicidal ideation was more than halved from the baseline
272                                              Suicidal ideation was not significantly associated with
273                                              Suicidal ideation was reported by 12.7% of all patients
274  across psychiatric diagnoses for predicting suicidal ideation was SLC4A4, with a receiver operating
275                                              Suicidal ideation was the main outcome, measured first b
276                  The prevalences of NSSI and suicidal ideation were 4.7% and 26.5%, respectively, and
277 atios (ORs) of suicide, suicide attempt, and suicidal ideation were analyzed using multilevel meta-an
278      The rates of symptoms of PTSD, MDD, and suicidal ideation were higher among former combatants th
279                        Ketamine's effects on suicidal ideation were partially independent of its effe
280 ated with increased likelihood of subsequent suicidal ideation, whereas recovery from burnout is asso
281 om burnout was associated with markedly less suicidal ideation, which suggests that recovery from bur
282 motor cortex-were indicators of remission of suicidal ideation with 89% accuracy, 90% sensitivity, an
283 lar disorder in particular, SLC4A4 predicted suicidal ideation with an AUC of 93%, and future hospita
284           For bipolar disorder, it predicted suicidal ideation with an AUC of 98%, and future hospita
285      Inclusion criteria were the presence of suicidal ideation with intent to die during the past wee
286  who either attempted suicide or experienced suicidal ideation with intent, were randomly assigned to
287 ic treatments suggests that ketamine reduces suicidal ideation with minimal adverse events compared w
288           We examined overweight/obesity and suicidal ideation with planning by gross domestic produc
289 erweight/obesity was positively related with suicidal ideation with planning for girls (odds ratio (O
290 and 7.5% of boys and 17.5% of girls reported suicidal ideation with planning over the last 12 months.
291    In contrast to overweight/obesity status, suicidal ideation with planning was not related to macro
292 h adolescent overweight/obesity but not with suicidal ideation with planning.
293 tatus, and 59,061 adolescents reported about suicidal ideation with planning.
294 association between depression, anxiety, and suicidal ideation with various dermatological diagnoses.
295 d a statistically nonsignificant increase in suicidal ideation with venlafaxine.
296  relationship between peer victimization and suicidal ideation, with a total of 284,375 participants.
297 th mental illness had a higher prevalence of suicidal ideation within the first year after surgery (n
298  and multiple TBIs, 21.7%; P = .009), as was suicidal ideation within the past year (0%, 3.4%, and 12
299 ents, and 11.2% (CI, 9.9% to 12.6%) reported suicidal ideation within the past year.
300 hypothesized that structures associated with suicidal ideation would be derived from a combination of

 
Page Top